EUVIMEDEUVIMED entdecken
Klinische Studie

Accuracy of FreeStyle Libre 3 During Moderate-Intensity Continuous Aerobic Exercise at Different Phases of the Menstrual Cycle in Females with Type 1 Diabetes

Alba Cuerda-Del Pino, Alejandro José Laguna Sanz iD, José-Luis Díez, Paolo Rossetti iD, Cynthia Marco Romero, F Javier Ampudia-Blasco, Jorge Bondia iD, Rodrigo Martín-San Agustín iD

Diabetes Technology & Therapeutics · 2025

DOI: 10.1089/dia.2024.0558 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Diabetes Technology & Therapeutics, 2025. Verfasst von Alba Cuerda-Del Pino und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinimetry and Technological Development in Therapeutic Exercise Research Group (CLIDET), Department of Physiotherapy, University of Valencia, Valenc…. Hauptthemen laut MEDLINE: Blood Glucose, Blood Glucose Self-Monitoring, Diabetes Mellitus, Type 1, Exercise. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The use of continuous glucose monitoring (CGM) devices in managing type 1 diabetes (T1D) has been associated with improved glycemic control in individuals with T1D. A key challenge for CGMs, however, is achieving accuracy, particularly under conditions where glucose levels may fluctuate rapidly, such as during exercise. Another factor contributing to blood glucose variability is the menstrual cycle, during which hormonal fluctuations affect insulin sensitivity, leading to variable glucose levels. This study aimed to assess the accuracy of FreeStyle Libre-3 (FSL3) during continuous moderate-intensity aerobic exercise (CONT) performed in the follicular and luteal phases of the menstrual cycle in females with T1D.

Methods

Participants underwent CONT sessions on a cycle ergometer, one in the follicular phase and one in the luteal phase of the menstrual cycle, at the Research Laboratory of the Faculty of Physiotherapy. Glucose levels were measured every 10 min using FSL3 and the YSI 2500 as a gold standard. Measurements began 20 min before CONT and continued for 20 min after exercise.

Results

A total of 26 females (mean age 32.2 ± 6.1 years and mean duration of diabetes 16.4 ± 8.4 years) participated in this study. FSL3 showed significant differences compared with YSI glucose data for both phases of the menstrual cycle (about 16 mg/dL higher in FSL3). There were no differences in mean absolute relative differences (MARDs) between the follicular (16.06%) and luteal (16.43) phases. Moreover, exercise did not affect MARDs, which were 14.21% pre-exercise and 17.63% postexercise for the follicular phase and 14.95% pre-exercise and 17.71% postexercise for the luteal phase.

Conclusions

The findings suggest that the accuracy of FSL3 is not affected by CONT, showing good accuracy levels in both phases of the menstrual cycle. Thus, this study is the first to examine the influence of the menstrual cycle and exercise on the accuracy of a CGM device. The study was also prospectively registered at clinicaltrials.gov (NCT06086067).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood GlucoseBlood Glucose Self-MonitoringDiabetes Mellitus, Type 1ExerciseMenstrual CycleAdultFemaleHumansYoung AdultFollicular PhaseLuteal PhaseReproducibility of Results

Stichwörter der Autor:innen

accuracycontinuous glucose monitoringmenstrual cyclemoderate-intensity continuous aerobic exercisetype 1 diabetes

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Clinimetry and Technological Development in Therapeutic Exercise Research Group (CLIDET), Department of Physiotherapy, University of Valencia, Valencia, Spain.
  • Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
  • Department of Electronic Engineering, University of Valencia, Valencia, Spain.
  • Instituto Universitario de Automática e Informática Industrial, Universitat Politècnica de València, València, Spain.
  • Department of Endocrinology & Nutrition, University and Polytechnic La Fe Hospital of Valencia, Spain.
  • INCLIVA Biomedical Research Institute, Valencia, Spain.

ORCID-Profile: Alejandro José Laguna Sanz, Paolo Rossetti, Jorge Bondia, Rodrigo Martín-San Agustín

Zitieren

APA

Cuerda-Del Pino, A., Laguna Sanz, A. J., Díez, J. L., Rossetti, P., Marco Romero, C., Ampudia-Blasco, F. J., Bondia, J., & Martín-San Agustín, R. (2025). Accuracy of FreeStyle Libre 3 During Moderate-Intensity Continuous Aerobic Exercise at Different Phases of the Menstrual Cycle in Females with Type 1 Diabetes. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2024.0558

Vancouver

Cuerda-Del Pino A, Laguna Sanz AJ, Díez JL, Rossetti P, Marco Romero C, Ampudia-Blasco FJ, et al. Accuracy of FreeStyle Libre 3 During Moderate-Intensity Continuous Aerobic Exercise at Different Phases of the Menstrual Cycle in Females with Type 1 Diabetes. Diabetes Technology & Therapeutics. 2025. doi:10.1089/dia.2024.0558

BibTeX
@article{CuerdaDelPino2025,
  author = {Cuerda-Del Pino, Alba and Laguna Sanz, Alejandro José and Díez, José-Luis and Rossetti, Paolo and Marco Romero, Cynthia and Ampudia-Blasco, F Javier and Bondia, Jorge and Martín-San Agustín, Rodrigo},
  title = {Accuracy of FreeStyle Libre 3 During Moderate-Intensity Continuous Aerobic Exercise at Different Phases of the Menstrual Cycle in Females with Type 1 Diabetes},
  journal = {Diabetes Technology & Therapeutics},
  year = {2025},
  doi = {10.1089/dia.2024.0558}
}
Kostenlos starten →